Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy

Clinical Immunology

Volumn 125, Issue 3, 2007, Pages 268-274

  Ding, Jia Xiang ^a   Xu, Li Xia ^a   Lv, Ji Cheng ^a   Zhao, Ming Hui ^a   Zhang, Hong ^a   Wang, Hai Yan ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Glycosylation; IgA nephropathy; Prognosis; Sialic acid

Indexed keywords

ALPHA 2, 6 SIALIC ACID; CREATININE; IMMUNOGLOBULIN A1; SIALIC ACID; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KAPLAN MEIER METHOD; KIDNEY BIOPSY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; SEX DIFFERENCE; SIALYLATION; SURVIVAL RATE;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; KAPLAN-MEIERS ESTIMATE; MALE; N-ACETYLNEURAMINIC ACID; PROGNOSIS;

EID: 36148931808     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.08.009     Document Type: Article

References (40)

1. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q. J. Med. 64 (1987) 709-727
2. Julian B.A., Waldo F.B., Rifai A., and Mestecky J. IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States?. Am. J. Med. 84 (1988) 129-132
3. D'Amico G., Colasanti G., Barbiano di Belgioioso G., Fellin G., Ragni A., Egidi F., Radaelli L., Fogazzi G., Ponticelli C., and Minetti L. Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients. Semin. Nephrol. 7 (1987) 355-358
4. Johnston P.A., Brown J.S., Braumholtz D.A., and Davison A.M. Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy. A report from the MRC Glomerulonephritis Registry. Q. J. Med. 84 (1992) 619-627
5. Radford Jr. M.G., Donadio J.V., Jr. E.J., and Bergstralh J.P. Predicting renal outcome in IgA nephropathy. J. Am. Soc. Nephrol. 8 (1997) 199-207
6. Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am. J. Kidney Dis. 29 (1997) 829-842
7. Bartosik L.P., Lajoie G., Sugar L., and Cattran D.C. Predicting progression in IgA nephropathy. Am. J. Kidney Dis. 38 (2001) 728-735
8. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin. Nephrol. 24 (2004) 179-196
9. Mestecky J., Tomana M., Crowley-Nowick P.A., Moldoveanu Z., Julian B.A., and Jackson S. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib. Nephrol. 104 (1993) 172-182
10. Allen A.C. Abnormal glycosylation of IgA: is it related to the pathogenesis of IgA nephropathy?. Nephrol. Dial. Transplant. 10 (1995) 1121-1124
11. Kokubo T., Hiki Y., Iwase H., Tanaka A., Nishikido J., Hotta K., and Kobayashi Y. Exposed peptide core of IgA1 hinge region in IgA nephropathy. Nephrol. Dial. Transplant. 14 (1999) 81-85
12. Hiki Y., Kokubo T., Iwase H., Masaki Y., Sano T., Tanaka A., Toma K., Hotta K., and Kobayashi Y. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J. Am. Soc. Nephrol. 10 (1999) 760-769
13. Amore A., Cirina P., Conti G., Brusa P., Peruzzi L., and Coppo R. Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J. Am. Soc. Nephrol. 12 (2001) 1862-1871
14. Coppo R., and Amore A. Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int. 65 (2004) 1544-1547
15. Allen A.C., Bailey E.M., Brenchley P.E., Buck K.S., Barratt J., and Feehally J. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int. 60 (2001) 969-973
16. Barratt J., Smith A.C., and Feehally J. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy. Nephrology (Carlton) 12 (2007) 275-284
17. Allen A.C., Bailey E.M., Barratt J., Buck K.S., and Feehally J. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J. Am. Soc. Nephrol. 10 (1999) 1763-1771
18. Allen A.C., Harper S.J., and Feehally J. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin. Exp. Immunol. 100 (1995) 470-474
19. Roos A., and van Kooten C. Underglycosylation of IgA in IgA nephropathy: more than a diagnostic marker?. Kidney Int. 71 (2007) 1089-1091
20. Leung J.C., Tang S.C., Chan D.T., Lui S.L., and Lai K.N. Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy. J. Clin. Lab. Anal. 16 (2002) 11-19
21. Hiki Y., Odani H., Takahashi M., Yasuda Y., Nishimoto A., Iwase H., Shinzato T., Kobayashi Y., and Maeda K. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 59 (2001) 1077-1085
22. Odani H., Hiki Y., Takahashi M., Nishimoto A., Yasuda Y., Iwase H., Shinzato T., and Maeda K. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry. Biochem. Biophys. Res. Commun. 271 (2000) 268-274
23. Leung J.C., Poon P.Y., and Lai K.N. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?. J. Lab. Clin. Med. 133 (1999) 152-160
24. Xu L.X., and Zhao M.H. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int. 68 (2005) 167-172
25. Ma Y.C., Zuo L., Chen J.H., Luo Q., Yu X.Q., Li Y., Xu J.S., Huang S.M., Wang L.N., Huang W., Wang M., Xu G.B., and Wang H.Y. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J. Am. Soc. Nephrol. 17 (2006) 2937-2944
26. Zuo L., Ma Y.C., Zhou Y.H., Wang M., Xu G.B., and Wang H.Y. Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am. J. Kidney Dis. 45 (2005) 463-472
27. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 39 (2002) S1-S266
28. Berger J., and Hinglais H. Intercapillary deposits of IgA-IgG. J. Urol. Nephrol. (Paris) 74 (1968) 694-695
29. Leung J.C., Tang S.C., Lam M.F., Chan T.M., and Lai K.N. Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy. Kidney Int. 59 (2001) 277-285
30. Kokubo T., Hiki Y., Iwase H., Tanaka A., Toma K., Hotta K., and Kobayashi Y. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J. Am. Soc. Nephrol. 9 (1998) 2048-2054
31. Tomana M., Novak J., Julian B.A., Matousovic K., Konecny K., and Mestecky J. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J. Clin. Invest. 104 (1999) 73-81
32. Kokubo T., Hashizume K., Iwase H., Arai K., Tanaka A., Toma K., Hotta K., and Kobayashi Y. Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy. Nephrol. Dial. Transplant. 15 (2000) 28-33
33. Tomana M., Matousovic K., Julian B.A., Radl J., Konecny K., and Mestecky J. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int. 52 (1997) 509-516
34. Marquina R., Diez M.A., Lopez-Hoyos M., Buelta L., Kuroki A., Kikuchi S., Villegas J., Pihlgren M., Siegrist C.A., Arias M., Izui S., Merino J., and Merino R. Inhibition of B cell death causes the development of an IgA nephropathy in (New Zealand white x C57BL/6)F(1)-bcl-2 transgenic mice. J. Immunol. 172 (2004) 7177-7185
35. Matsuda M., Shikata K., Wada J., Sugimoto H., Shikata Y., Kawasaki T., and Makino H. Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy. Nephron 80 (1998) 408-413
36. Moura I.C., Arcos-Fajardo M., Sadaka C., Leroy V., Benhamou M., Novak J., Vrtovsnik F., Haddad E., Chintalacharuvu K.R., and Monteiro R.C. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J. Am. Soc. Nephrol. 15 (2004) 622-634
37. Novak J., Vu H.L., Novak L., Julian B.A., Mestecky J., and Tomana M. Interactions of human mesangial cells with IgA and IgA-containing immune complexes. Kidney Int. 62 (2002) 465-475
38. Gomez-Guerrero C., Gonzalez E., and Egido J. Evidence for a specific IgA receptor in rat and human mesangial cells. J. Immunol. 151 (1993) 7172-7181
39. Chen A., Chen W.P., Sheu L.F., and Lin C.Y. Pathogenesis of IgA nephropathy: in vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion. J. Pathol. 173 (1994) 119-126
40. Gomez-Guerrero C., Lopez-Armada M.J., Gonzalez E., and Egido J. Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. J. Immunol. 153 (1994) 5247-5255